Hepatic steatosis induced in C57BL/6 mice by a non-ß oxidizable fatty acid analogue is associated with reduced plasma kynurenine metabolites and a modified hepatic NAD+/NADH ratio
Abstract Background Non-alcoholic fatty liver disease is often associated with obesity, insulin resistance, dyslipidemia, and the metabolic syndrome in addition to mitochondrial dysfunction and nicotinamide adenine dinucleotide (NAD+) deficiency. The aim of this study was to investigate how inhibiti...
Main Authors: | Rolf K. Berge, Daniel Cacabelos, Rosa Señarís, Jan Erik Nordrehaug, Ottar Nygård, Jon Skorve, Bodil Bjørndal |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-05-01
|
Series: | Lipids in Health and Disease |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12944-020-01271-1 |
Similar Items
-
Metabolic Rewiring of Kynurenine Pathway during Hepatic Ischemia–Reperfusion Injury Exacerbates Liver Damage by Impairing NAD Homeostasis
by: Bowen Xu, et al.
Published: (2022-12-01) -
The Kynurenine Pathway and Cancer: Why Keep It Simple When You Can Make It Complicated
by: Roumaïssa Gouasmi, et al.
Published: (2022-06-01) -
The immunomodulatory role of IDO1-Kynurenine-NAD+ pathway in switching cold tumor microenvironment in PDAC
by: R. I. Anu, et al.
Published: (2023-06-01) -
Kynurenine acid - metabolism and regulation of kynurenine pathway
by: Piotr Kozłowski, et al.
Published: (2017-07-01) -
Kynurenine Pathway in Psoriasis—a Promising Link?
by: A. Stepaniuk, et al.
Published: (2023-06-01)